MAPK13 antibody (Middle Region)
Quick Overview for MAPK13 antibody (Middle Region) (ABIN928853)
Target
See all MAPK13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Purification
- Purified
-
Immunogen
- MAPK13 antibody was raised in rabbit using the middle region of MAPK13 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
MAPK13 Blocking Peptide, (ABIN937976), is also available for use as a blocking control in assays to test for specificity of this MAPK13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAPK13 (Mitogen-Activated Protein Kinase 13 (MAPK13))
-
Alternative Name
- MAPK13
-
Background
- The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is closely related to p38 MAP kinase, both of which can be activated by proinflammatory cytokines and cellular stress. MAP kinase kinases 3, and 6 can phosphorylate and activate this kinase. Transcription factor ATF2, and microtubule dynamics regulator stathmin have been shown to be the substrates of this kinase. Synonyms: Polyclonal MAPK13 antibody, Anti-MAPK13 antibody, mitogen-activated protein kinase 13 antibody, MGC99536 antibody, PRKM13 antibody, SAPK4 antibody, p38delta antibody.
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway, Hepatitis C, BCR Signaling, S100 Proteins
Target
-